McDermott + Bull has successfully placed Avyaya (Avi) Sharma as the Vice President of Clinical Affairs at Adagio Medical, Inc. He will be charged with overseeing and managing the company’s sponsored global pre-market and post-market clinical studies and is currently driving the enrollment and completion of Adagio’s newly initiated IDE study.
Avi brings a tremendous amount of experience leading clinical and regulatory programs for high-growth medical companies. He has led dozens of successful IDE studies from inception to completion within the cardiovascular space. His background in business and clinical strategy will prove crucial to this role.
Adagio Medical, a privately held medical device company located in Laguna Hills, California, is developing innovative cryoablation technologies that create continuous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. Adagio Medical is a Fjord Ventures portfolio company.